These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16252375)

  • 1. Effect of antipsychotics on mortality in elderly patients with dementia: a 1-year prospective study in a nursing home.
    Suh GH; Shah A
    Int Psychogeriatr; 2005 Sep; 17(3):429-41. PubMed ID: 16252375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortality in Alzheimer's disease: a comparative prospective Korean study in the community and nursing homes.
    Suh GH; Kil Yeon B; Shah A; Lee JY
    Int J Geriatr Psychiatry; 2005 Jan; 20(1):26-34. PubMed ID: 15578675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shifting from haloperidol to risperidone for behavioral disturbances in dementia: safety, response predictors, and mood effects.
    Lane HY; Chang YC; Su MH; Chiu CC; Huang MC; Chang WH
    J Clin Psychopharmacol; 2002 Feb; 22(1):4-10. PubMed ID: 11799336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
    De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
    Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are all commonly prescribed antipsychotics associated with greater mortality in elderly male veterans with dementia?
    Rossom RC; Rector TS; Lederle FA; Dysken MW
    J Am Geriatr Soc; 2010 Jun; 58(6):1027-34. PubMed ID: 20487081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.
    Declercq T; Petrovic M; Azermai M; Vander Stichele R; De Sutter AI; van Driel ML; Christiaens T
    Cochrane Database Syst Rev; 2013 Mar; (3):CD007726. PubMed ID: 23543555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blind, crossover comparison of risperidone and haloperidol in Korean dementia patients with behavioral disturbances.
    Suh GH; Son HG; Ju YS; Jcho KH; Yeon BK; Shin YM; Kee BS; Choi SK
    Am J Geriatr Psychiatry; 2004; 12(5):509-16. PubMed ID: 15353389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The switching of risperidone to olanzapine in elderly nursing-home patients with dementia: a retrospective study.
    Madhusoodanan S; Bogunovic O
    CNS Spectr; 2007 Jan; 12(1):46-50. PubMed ID: 17192763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind randomised comparison of risperidone and haloperidol in the treatment of behavioural and psychological symptoms in Chinese dementia patients.
    Chan WC; Lam LC; Choy CN; Leung VP; Li SW; Chiu HF
    Int J Geriatr Psychiatry; 2001 Dec; 16(12):1156-62. PubMed ID: 11748775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipsychotic use and mortality risk in community-dwelling Alzheimer's disease patients: evidence for a role of dementia severity.
    Gardette V; Lapeyre-Mestre M; Coley N; Cantet C; Montastruc JL; Vellas B; Andrieu S
    Curr Alzheimer Res; 2012 Nov; 9(9):1106-16. PubMed ID: 22950915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia.
    Brodaty H; Ames D; Snowdon J; Woodward M; Kirwan J; Clarnette R; Lee E; Lyons B; Grossman F
    J Clin Psychiatry; 2003 Feb; 64(2):134-43. PubMed ID: 12633121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial.
    Ballard C; Hanney ML; Theodoulou M; Douglas S; McShane R; Kossakowski K; Gill R; Juszczak E; Yu LM; Jacoby R;
    Lancet Neurol; 2009 Feb; 8(2):151-7. PubMed ID: 19138567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical antipsychotics for nursing home patients: a retrospective chart review.
    Frenchman IB
    Drugs Aging; 2005; 22(3):257-64. PubMed ID: 15813657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risperidone for psychosis of Alzheimer's disease and mixed dementia: results of a double-blind, placebo-controlled trial.
    Brodaty H; Ames D; Snowdon J; Woodward M; Kirwan J; Clarnette R; Lee E; Greenspan A
    Int J Geriatr Psychiatry; 2005 Dec; 20(12):1153-7. PubMed ID: 16315159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of antipsychotic drug treatment on prolactin concentrations in elderly patients.
    Kinon BJ; Stauffer VL; McGuire HC; Kaiser CJ; Dickson RA; Kennedy JS
    J Am Med Dir Assoc; 2003; 4(4):189-94. PubMed ID: 12837139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase in mortality rate in patients with dementia treated with atypical antipsychotics: a cohort study in outpatients in Central Italy.
    Piersanti M; Capannolo M; Turchetti M; Serroni N; De Berardis D; Evangelista P; Costantini P; Orsini A; Rossi A; Maggio R
    Riv Psichiatr; 2014; 49(1):34-40. PubMed ID: 24572582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of risk of cerebrovascular events in an elderly VA population with dementia between antipsychotic and nonantipsychotic users.
    Barnett MJ; Wehring H; Perry PJ
    J Clin Psychopharmacol; 2007 Dec; 27(6):595-601. PubMed ID: 18004126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group.
    Katz IR; Jeste DV; Mintzer JE; Clyde C; Napolitano J; Brecher M
    J Clin Psychiatry; 1999 Feb; 60(2):107-15. PubMed ID: 10084637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm.
    Maust DT; Kim HM; Seyfried LS; Chiang C; Kavanagh J; Schneider LS; Kales HC
    JAMA Psychiatry; 2015 May; 72(5):438-45. PubMed ID: 25786075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low incidence of persistent tardive dyskinesia in elderly patients with dementia treated with risperidone.
    Jeste DV; Okamoto A; Napolitano J; Kane JM; Martinez RA
    Am J Psychiatry; 2000 Jul; 157(7):1150-5. PubMed ID: 10873925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.